Day: Biotech
Needs Review
MaxL: New life science accelerator opens in Martinsried
The Bavarian Ministry of Economic Affairs is supporting the development of the Munich Accelerator Life Sciences & Medicine, or MAxL for short, in Martinsried with €8.5 million.
Needs Review
Plectonic Biotech receives Sprind funding
The Federal Agency for Disruptive Innovations – Sprind for short – will finance the work of the TUM spin-off Plectonic Biotech in the coming years.…
Deals
Catalym secures 50 million euros
Catalym raises €50 million in a Series C round. The Martinsried-based biotech startup plans to use the newly raised capital…
Podcast
Cutting-edge research meets application: Biotech from Munich
With the Innovation and Start-up Center for Biotechnology (IZB) and numerous startups in the industry, Munich is considered Germany's biotech hotspot. In…
Inside Stories
Biotech industry: Investments remain at record levels
In 2020, the first year of the coronavirus pandemic, the German biotech industry raised €3.1 billion. Last year, investments were somewhat lower,…
Deals
Tubulis closes Series B with 60 million euros
Tubulis secures €60 million ($63 million) in its Series B funding. The round is led by Andera Partners.…
Deals
Eisbach Bio receives 6.7 million euros from the Bavarian State Government
The Munich-based biotech company Eisbach Bio has received funding of 6.7 million euros for the development of antiviral agents against…
Inside Stories
Munich is an outstanding biotech location in Germany
According to a recent study, 21 percent of Germany-based biotechnology companies are headquartered in the European Metropolitan Region of Munich (EMM).…
Deals
Nine million euros for HMNC Brain Health
HMNC Brain Health, a Munich-based biotech company specializing in the development of personalized therapies for depression and other neuropsychiatric disorders…
Deals
Eisbach Bio receives 8 million euros in state funding
Eisbach Bio has received funding from the German Federal Ministry of Education and Research (BMBF) for the clinical development of a COVID-19 drug…
Competition
Munich Life Science Pitch Day: Application period open
On September 30, 2021, the Innovation and Start-up Center for Biotechnology (IZB), in cooperation with High-Tech Gründerfonds and Bayer AG, will…
Deals
Origin.Bio secures 12 million euros
Origin.Bio, which aims to make petrochemicals obsolete with its technology, is receiving €12.3 million in investment capital. The fresh capital will…
